Archives
-
From Superoxide Signals to Antitumor Immunity
2026-09-17
A translational roadmap for using intracellular superoxide measurement to connect TrxR/MAPK biology, oxidative stress assay design, and emerging immuno-oncology strategies.
-
ABT-199 (GDC-0199): Bcl-2 Inhibitor Guide
2026-09-17
This dossier-based guide explains how to handle ABT-199 (GDC-0199), also known as Venetoclax, in selective Bcl-2 inhibition and apoptosis workflows. It is intended for controlled in vitro and research-model experiments, not for clinical dosing, diagnosis, or direct transfer of the reported murine dose into cell culture.
-
Parathyroid hormone (1-34) (human) in KPA Research
2026-09-16
Use Parathyroid hormone (1-34) (human) to connect receptor pharmacology with spatially organized kidney assembloids and bone-focused assays. This guide translates reported potency and in vivo bone findings into practical workflows, controls, and troubleshooting strategies for calcium-signaling research.
-
TH287 MTH1 Inhibitor for Radiosensitization
2026-09-16
TH287 is a potent MTH1 inhibitor for modeling oxidative nucleotide stress, cancer-cell-selective DNA damage, and radiotherapy sensitization. A timing-focused workflow based on CRPC research helps laboratories separate direct cytotoxicity from true combination effects.
-
DiscoveryProbe Protease Inhibition, Beyond Screening
2026-09-15
Protease inhibitors are most valuable when screening is connected to mechanism. This thought-leadership article uses plant chemical biology as a model for translating protease activity modulation into stronger assay design, target validation, and therapeutic strategy with the DiscoveryProbe™ Protease Inhibitor Library.
-
Dinaciclib: A Mechanical View of CDK Biology
2026-09-15
Dinaciclib (SCH727965) is examined as more than a proliferation inhibitor: it is a tool for separating cell-cycle control, apoptosis, and tissue-boundary mechanics. Grounded in a 2026 Drosophila study, this guide shows how to design cancer research assays that distinguish reduced division from genuine changes in cell rearrangement.
-
Vitamin C and ROS/NF-κB in Cochlear Senescence
2026-09-14
A 2024 Molecular Biology Reports study shows that Vitamin C reduces D-galactose-induced senescence in HEI-OC1 cochlear hair cells, alongside lower oxidative stress, inflammatory signaling, and NF-κB activation. The findings position the ROS/NF-κB axis as a mechanistic framework for studying cellular contributors to age-related hearing loss, while remaining limited to an in vitro model.
-
Dihydroartemisinin: From Identity to Assay Design
2026-09-14
Dihydroartemisinin is a defined Artemisia plant-derived compound with applications spanning malaria, mTOR, inflammation, and psoriasis research. This article explains how to interpret its chemistry, select assays, control formulation variables, and use the phebestin study as a model for stronger antiplasmodial decision-making.
-
Kidney Progenitor Assembloids for Disease Modeling
2026-09-13
Huang et al. developed spatially patterned mouse and human kidney progenitor assembloids that reproduce key self-assembly relationships between nephron and ureteric progenitors. The models improve cellular organization, maturation, and functional assessment, while in vivo-grown PKD2-deficient human assembloids provide a higher-fidelity system for studying polycystic kidney disease and interactions among cyst epithelium, stroma, and macrophages.
-
EZ Cap EGFP mRNA 5-moUTP: Mechanism & Use
2026-09-12
EZ Cap EGFP mRNA 5-moUTP is a Cap1-capped, 5-moU-modified EGFP reporter transcript designed for stable protein expression. Its defined 996-nucleotide format, approximately 100-nucleotide poly(A) tail, and RNase-conscious handling support reproducible mRNA delivery for gene expression and imaging workflows.
-
FLCN Mutations and mRNA Rescue in BHD Syndrome
2026-09-11
This 2026 study identified a novel FLCN nonsense mutation, p.Q44*, and provided segregation and functional evidence supporting pathogenic reclassification of p.W376R in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, synthetic FLCN mRNA restored folliculin expression and corrected mTORC1 dysregulation, offering preliminary—not clinical—evidence for an mRNA protein-replacement strategy.
-
MK-571 and L-660,711 in LPS-Protected Macrophages
2026-09-11
The reference study shows that lipopolysaccharide protects RAW264.7 macrophages from antitumor drug-induced injury through a pathway involving system Xc−, glutathione synthesis, and ABCC1-associated drug handling. Its use of MK-571 identifies a mechanistic connection between transporter activity and redox defense, while also requiring careful interpretation because MK-571 has independent leukotriene receptor pharmacology.
-
Thiothixene for Efferocytosis and Schizophrenia Research
2026-09-10
Thiothixene offers a practical bridge between dopamine-receptor pharmacology and macrophage clearance biology. This workflow shows how to test its 2 μM in vitro starting point, separate efferocytosis-specific effects from toxicity, and use schizophrenia genetics as a translational framework without overstating mechanistic links.
-
Dexamethasone: Genotype-Aware Assay Design
2026-09-10
Dexamethasone is a powerful glucocorticoid anti-inflammatory for dissecting NF-κB activity, differentiation, autophagy, and neuroinflammation. This article introduces a genotype-aware framework for choosing cell models and interpreting response variability using insights from multiple myeloma genomics.
-
Reactive Oxygen Species Assay Kit: DHE in Macrophages
2026-09-09
Explore how the Reactive Oxygen Species Assay Kit (DHE) can connect intracellular superoxide measurement with DON-induced macrophage immunotoxicity. This evidence-led guide explains assay chemistry, controls, interpretation limits, and orthogonal validation strategies.